Sanofi joins effort to alter 340B program
Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22. 340B compels drugmakers to offer discounted …